Sun Pharma
Sensex rebounds from 2,300-point fall after Budget proposals spark volatility
Profit-taking, FII outflows pull indices down after record intraday peaks
Sun Pharma Q2 profit rises 2.5% to Rs 3,118 crore on strong India, emerging market sales
US tariffs: Sun Pharma faces headline risk, but limited earnings impact
Pharma stocks decline after Trump's import tariffs; Wockhardt tumbles over 6%
Sensex declines in early trade dragged by pharma stocks, relentless FII outflows
Sensex tumbles 849 pts, slips below 81K, ahead of additional 25% US tariffs
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg)
/newsdrum-in/media/media_files/2026/02/04/sun-pharma-rcb-sponsor-2026-02-04-14-41-02.jpg)
/newsdrum-in/media/media_files/2025/04/07/share-market-crash-sensex-stock-market-crash-823155.jpg)
/newsdrum-in/media/media_files/2025/03/10/QqHk9f8hqwMzlMxvbt8A.jpg)
/newsdrum-in/media/media_files/K3ct3JfzbrdcO7CjNoFW.jpg)
/newsdrum-in/media/media_files/2025/08/01/sun-pharma-logo-2025-08-01-11-34-30.jpg)
/newsdrum-in/media/media_files/2025/09/26/indian-pharma-stocks-pharmaceutical-pharmacy-medicines-drugs-vaccine-2025-09-26-18-00-42.jpg)
/newsdrum-in/media/media_files/6iFnMKWCJbZ9gXA3raVU.jpg)
